Epigenetic Exceptionalism

Murray T. H. , “Genetic Exceptionalism and ‘Future Diaries’: Is Genetic Information Different from Other Medical Information?” in Rothstein M. A. , ed., Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era (New Haven: Yale University Press, 1997).

See, e.g., Gostin L. O. Hodge J. G. Jr. , “Genetic Privacy and the Law: An End to Genetics Exceptionalism,” Jurimetrics Journal 40, no. 1 (1999): 21–58; Hellman D. , “What Makes Genetic Discrimination Exceptional?” American Journal of Law & Medicine 29, no. 1 (2003): 77–116; Lemmens T. , “Selective Justice, Genetic Discrimination, and Insurance: Should We Single Out Genes in Our Laws?” McGill Law Journal 45, no. 2 (2000): 347–412; Suter S. M. , “The Allure and Peril of Genetic Exceptionalism: Do We Need Special Genetics Legislation?” Washington University Law Quarterly 79, no. 3 (2001): 669–748.

Rothstein M. A. , “Genetic Exceptionalism and Legislative Pragmatism,” Hastings Center Report 35, no. 4 (2005): 27–33.

Id.

Rothstein M. A. Cai Y. Marchant G. E. , “The Ghost in Our Genes: Legal and Ethical Implications of Epigenetics,” Health Matrix 19, no. 1 (2009): 1–62.

Jirtle R. L. Skinner M. K. , “Environmental Epigenomics and Disease Susceptibility,” Nature Reviews Genetics 8, no. 2 (2007): 253–262; Szyf M. , “The Dynamic Epigenome and Its Implications in Toxicology,” Journal of Toxicological Science 100, no. 1 (2007): 7–23.

See Jirtle R. L. Tyson F. L. , eds., Environmental Epigenomics in Health and Disease (New York: Springer-Verlag, 2013).

Bird A. , “DNA Methylation Patterns and Epigenetic Memory,” Genes and Development 16, no. 1 (2002): 6–21.

Watson R. E. Goodman J. I. , “Epigenetics and DNA Methylation Come of Age in Toxicology,” Toxicological Sciences 67, no. 1 (2002): 11–16.

Vertino P. M. , “DNMT1 Is a Component of a Multiprotein DNA Replication Complex,” Cell Cycle 1, no. 6 (2002): 416–423.

Jones P. A. Baylin S. B. , “The Epigenomics of Cancer,” Cell 128, no. 4 (2007): 683–692.

See Jirtle Skinner , supra note 6, at 258.

Dolinoy D. C. Weidman J. R. Jirtle R. L. , “Epigenetic Gene Regulation: Linking Early Developmental Environment to Adult Disease,” Reproductive Toxicology 23, no. 4 (2007): 297–307.

Feinberg A. P. , “Epigenetics at the Epicenter of Modern Medicine,” JAMA 299, no. 11 (2008): 1345–1350.

Herceg Z. Hainaut P. , “Genetic and Epigenetic Alterations as Biomarkers for Cancer Detection, Diagnosis and Prognosis,” Molecular Oncology 1, no. 1 (2007): 26–41; see Szyf , supra note 6.

Id. (Szyf), at 13–14.

See Jirtle Skinner , supra note 6, at 256.

Id.; see Szyf , supra note 6.

See Hedlund M. , “Epigenetic Responsibility,” Medicine Studies 3, no. 3 (2012): 171–183; Khan F. , “Preserving Human Potential as Freedom: A Framework for Regulating Epigenetic Harms,” Health Matrix 20, no. 2 (2010): 259–323.

Pembrey M. E. , “Sex-Specific, Male-Line Transgenerational Responses in Humans,” European Journal of Human Genetics 14, no. 1 (2006): 159–166.

See Sharp R. R. Marchant G. E. Grodsky J. A. , eds., Genomics and Environmental Regulation: Science, Ethics, and Law (Baltimore: Johns Hopkins University Press, 2008).

GINA §§ 101(4)(A), 201(4)(A).